Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1506049

registered interest
date	07/09/2022
answering body	Women and Equalities
answering dept id	31
answering dept short name	Women and Equalities
answering dept sort name	Women and Equalities
hansard heading	Women and Equalities: Departmental Responsibilities
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for Women and Equalities, what his responsibilities are; and when he plans to populate the responsibilities section of the Minister for Equalities webpage on www.gov.uk which appeared blank when that page was access on 7 September 2022.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	49246
answer	answer is ministerial correction date of answer 23/09/2022 answer text <p>The equalities brief has not changed and Ministers and officials will continue to be focused on women and equalities issues as before. Gov.uk pages will be updated in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/09/2022 13:04:46 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4657 label Biography information for Anneliese Dodds

1354376

registered interest
date	09/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether members of the public who received doses of Astra Zeneca 4120Z001, 4120Z002, 4120Z003 will be entitled to receive a third dose of a vaccination recognised by the European Medicines Agency.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	45808
answer	answer is ministerial correction date of answer 14/09/2021 answer text <p>Members of the public will not be entitled to receive a third dose of a COVID-19 vaccination on the basis of having received doses of AstraZeneca with batch numbers 4120Z001, 4120Z002, 4120Z003. All AstraZeneca vaccine doses administered in the United Kingdom are the same COVID-19 vaccine and have been authorised for use under Regulation 174, having met the strict standards on safety, quality and efficacy.</p><p>The decision to accept a particular vaccine is ultimately for individual European Union Member States. The EU has published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency for the purposes of travel includes all vaccines administered in the UK, including all batches of AstraZeneca COVID-19 vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/09/2021 15:34:16 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1438 label Biography information for Lord Beamish

1353907

registered interest
date	08/09/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	GKN: Birmingham
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential merits of providing grants to support the transition of the GKN Driveline factory in Birmingham to produce components for electric vehicles.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	45102
answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>The Government has no role in setting the strategic direction or priorities of private sector businesses. As part of the mandatory consultation process on the future of the GKN Driveline factory in Birmingham, the government secured assurances from GKN Automotive that they would consider viable alternatives to closure, including repurposing the plant to produce components for electric vehicles.</p><p> </p><p>Alternative proposals were submitted as part of the consultation. After careful consideration, GKN regrettably concluded there were no viable alternatives to closure.</p><p> </p><p>The government is maintaining a dialogue about the site’s future, actively marketing the site and is working with GKN and local partners to provide support and guidance to the GKN employees. Any potential future commercial propositions for the Birmingham site will be assessed on their own merits.</p><p> </p><p>The Government remains fully committed to working in partnership with industry to support the automotive sector’s transition to zero emission vehicles. Nearly £500m has been made available through the Automotive Transformation Fund to build an internationally competitive electric vehicle supply chain as part of my Rt. Hon. Friend the Prime Minister’s 10 Point Plan. This will create thousands of well-paid green jobs in our industrial heartlands, including the West Midlands.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 15:43:12 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 21087 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3973 label Biography information for Grahame Morris

1354003

registered interest
date	08/09/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Electric Vehicles: Rural Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent assessment he has made of the impact of banning the sale of new petrol and diesel cars by 2030 on people living off the electric grid; and what assessment he has made of the support required by those people living off-grid to assist in the transition to using electric vehicles.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	45240
answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>The Government had already committed £1.5 billion to support the early market and remove barriers to zero emission vehicles ownership. Alongside the new phase out dates we have pledged a further £2.8 billion package of measures to support industry and consumers to make the switch to cleaner vehicles.</p><p> </p><p>The Government wants to ensure everyone, including those without access to the electricity grid can still benefit from the transition to zero emission vehicles. The On-Street Residential Chargepoint Scheme (ORCS) is available to all UK local authorities to provide public chargepoints for their residents including those without access to the electricity grid.  Drivers may also chose to charge their vehicle at their workplace, or when they do their shopping.</p><p> </p><p>The forthcoming EV Infrastructure Strategy will also set out Government’s vision for the future of EV charging. A strong focus will be on the needs of those who cannot rely on off-street charging. Local authorities and Chargepoint operators should work together to provide sufficient levels of provision in order to meet demand.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 10:29:07 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 21090 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4630 label Biography information for Ben Lake

1353505

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has for a covid-19 vaccine booster campaign in autumn 2021.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	44364
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021, which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine, and flu vaccine, as soon as possible from September, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply and approvals by the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:46:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4385 label Biography information for Dr Philippa Whitford

1353507

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long term monitoring of immunity in people who have received different covid-19 vaccines for each dose.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	44365
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose.</p><p>Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The antibody results will be published in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 09:07:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4385 label Biography information for Dr Philippa Whitford

1353563

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus Certificates: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 July 2021 to Question 31551, when UK residents vaccinated against covid-19 while overseas with a (a) Pfizer, (b) Oxford-AstraZeneca and (c) Moderna vaccine are able to be certified as vaccinated by the UK.
tabling member constituency	North East Bedfordshire
tabling member printed	Richard Fuller
uin	44282
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>Work is underway to determine which non-Medicines and Healthcare products Regulatory Agency authorised vaccines we will recognise with confidence to enable United Kingdom residents vaccinated abroad to demonstrate their vaccination status. A solution will be rolled out in England as a pilot from the end of September.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:36:09 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3912 label Biography information for Richard Fuller

1353571

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Homes: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the policy that staff at CQC-registered care homes must have received both covid-19 doses from 11 November 2021 on staffing levels in those homes.
tabling member constituency	Richmond Park
tabling member printed	Sarah Olney
uin	44423
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Department has published an impact statement detailing the expected effect of the vaccination as a condition of deployment policy on care homes. The department will publish a full impact assessment in due course. We continue to monitor the impact of the policy on care homes as we approach 11 November.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:48:13 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4591 label Biography information for Sarah Olney

1353594

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk covid-19 poses to unvaccinated pregnant women; and what steps he is taking to ensure pregnant women receive both doses of the vaccine before their third trimester.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	44411
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>Although the overall risk from COVID-19 in pregnant women is low, in later pregnancy some women may become seriously unwell and need hospital treatment. Pregnant women with COVID-19 have a higher risk of intensive care admission than women of the same age who are not pregnant. Women with COVID-19 disease are also 2-3 times more likely to have their babies early than women without COVID-19. Pregnant women with underlying clinical conditions are at even higher risk of suffering serious complications from COVID-19.</p><p> </p><p>Currently, the Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of 8 weeks between doses of all the available COVID-19 vaccines; this includes pregnant women. It is important to note that current evidence shows that a longer dose interval produces a better immune response. The JCVI regularly reviews its advice in relation to COVID-19 Vaccination Programme, taking into account new data and evidence on the effectiveness of the programme and epidemiological situation.</p><p> </p><p>We are working hard to drive uptake in pregnant women, to ensure that as many pregnant women take up the offer of vaccination as soon as possible so that they are protected throughout their pregnancy. It is understood that pregnant women may prefer to wait to be vaccinated until after they have given birth. It is important for pregnant women to discuss their offer of vaccination with a healthcare professional in relation to the risks and benefits of the vaccine.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:44:02 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1353595

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of bringing forward pregnant women's second doses of the covid-19 vaccine before their third trimester.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	44412
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>Currently, the Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of eight weeks between doses of all the available COVID-19 vaccines; this includes pregnant women. On 14 May 2021, in response to the increasing rates of infection of the Delta variant, the Government amended the interval of second doses for the most vulnerable cohorts who were offered a vaccine in phase one of the programme, from 12 weeks to an eight-week gap. The eight-week dose interval was applied to all eligible cohorts from 6 July.</p><p>It should be noted that current evidence shows that a longer dose interval produces a better immune response. As such, the JCVI has advised against reducing the dose interval further in order to maximise the effectiveness of the vaccination programme. The JCVI regularly reviews its advice in relation to COVID-19 vaccinations, taking into account new data and evidence on the effectiveness of the programme and the ongoing epidemiological situation<em>.</em></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 10:26:14 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes